January 1997

Dominant Optic Atrophy, Kjer TypeLinkage Analysis and Clinical Features in a Large British Pedigree

Author Affiliations

From the Department of Ophthalmology, St Thomas's Hospital (Drs Johnston, Burdon, and Spalton), and Division of Medical and Molecular Genetics, Guy's Hospital (Drs Behnam and Seller), London, England; and Human Genetic Resources Laboratory, Imperial Cancer Research Fund, South Mimms, England (Mr Bryant).

Arch Ophthalmol. 1997;115(1):100-103. doi:10.1001/archopht.1997.01100150102017

Objectives:  To perform DNA linkage studies in an extensive 5-generation British pedigree with dominant optic atrophy and to validate the efficacy of domiciliary screening for affected members.

Methods:  Family members received a domiciliary examination based on corrected visual acuity, color vision, visual field defects, and optic disc appearance; DNA linkage analysis was performed using 7 microsatellite markers on 3q27-qter.

Results:  Based on the results of the ophthalmic examination, 15 members could be classified as definitely affected, 1 probably affected, and 25 unaffected. Two-point linkage analysis gave significant maximum lod scores at u = 0.00, with the markers D3S3669, D3S3590, and D3S3642. A haplotype segregating with the disease was identified in affected individuals, including the probably affected subject. Informative meioses defined the disease interval between markers D3S1601 and D3S1265.

Conclusions:  Domiciliary screening was effective in identifying all 16 affected members of a British family with dominant optic atrophy. The typical clinical features were present. The location of the OPA1 gene in this new British family seems to be in the 3q27-28 region and is the same as that reported in Danish, Cuban, and French families, suggesting no genetic heterogeneity in this disorder.